Arsenic exposure and prevalence of diabetes mellitus in Korean adults

Journal of Korean Medical Science

Volumn 28, Issue 6, 2013, Pages 861-868

  Rhee, Sang Youl ^a   Hwang, You Cheol ^a   Woo, Jeong taek ^a   Chin, Sang Ouk ^a   Chon, Suk ^a   Kim, Young Seol ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Arsenic; Arsenic poisoning; Blood glucose; Diabetes mellitus; Hyperglycemia; Insulin resistance; KNHANES; Korea

Indexed keywords

EID: 84880006461     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2013.28.6.861     Document Type: Article

References (32)

1. Lai MS, Hsueh YM, Chen CJ, Shyu MP, Chen SY, Kuo TL, Wu MM, Tai TY. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol 1994; 139: 484-92.
2. Rahman M, Tondel M, Ahmad SA, Axelson O. Diabetes mellitus associated with arsenic exposure in Bangladesh. Am J Epidemiol 1998; 148: 198-203.
3. Coronado-González JA, Del Razo LM, García-Vargas G, Sanmiguel-Salazar F, Escobedo-de la Peña J. Inorganic arsenic exposure and type 2 diabetes mellitus in Mexico. Environ Res 2007; 104: 383-9.
4. Jensen GE, Hansen ML. Occupational arsenic exposure and glycosylated haemoglobin. Analyst 1998; 123: 77-80.
5. Navas-Acien A, Silbergeld EK, Streeter RA, Clark JM, Burke TA, Guallar E. Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence. Environ Health Perspect 2006; 114: 641-8.
6. Chen CJ, Wang SL, Chiou JM, Tseng CH, Chiou HY, Hsueh YM, Chen SY, Wu MM, Lai MS. Arsenic and diabetes and hypertension in human populations: a review. Toxicol Appl Pharmacol 2007; 222: 298-304.
7. Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 2008; 300: 814-22.
8. Longnecker MP, Daniels JL. Environmental contaminants as etiologic factors for diabetes. Environ Health Perspect 2001; 109: 871-6.
9. Ruiz-Navarro ML, Navarro-Alarcón M, Lopez González-de la Serrana H, Pérez-Valero V, López-Martinez MC. Urine arsenic concentrations in healthy adults as indicators of environmental contamination: relation with some pathologies. Sci Total Environ 1998; 216: 55-61.
10. Lamm SH, Engel A, Feinleib M. Arsenic exposure and diabetes mellitus risk. J Occup Environ Med 2006; 48: 1001-3.
11. Zierold KM, Knobeloch L, Anderson H. Prevalence of chronic diseases in adults exposed to arsenic-contaminated drinking water. Am J Public Health 2004; 94: 1936-7.
12. Wang SL, Chang FH, Liou SH, Wang HJ, Li WF, Hsieh DP. Inorganic arsenic exposure and its relation to metabolic syndrome in an industrial area of Taiwan. Environ Int 2007; 33: 805-11.
13. Chen Y, Ahsan H, Slavkovich V, Peltier GL, Gluskin RT, Parvez F, Liu X, Graziano JH. No association between arsenic exposure from drinking water and diabetes mellitus: a cross-sectional study in Bangladesh. En viron Health Perspect 2010; 118: 1299-305.
14. Ministry of Health & Welfare. 2008 National Health Statistics. Available at http://knhanes.cdc.go.kr/knhanes/index.do [accessed on 28 December 2012].
15. Ministry of Health & Welfare. 2009 National Health Statistics. Available at http://knhanes.cdc.go.kr/knhanes/index.do [accessed on 28 December 2012].
16. Kim Y, Lee BK. Association between urinary arsenic and diabetes mellitus in the Korean general population according to KNHANES 2008. Sci Total Environ 2011; 409: 4054-62.
17. Park HS, Park CY, Oh SW, Yoo HJ. Prevalence of obesity and metabolic syndrome in Korean adults. Obes Rev 2008; 9: 104-7.
18. International Standard Classification of Occupations. The International Standard Classification of Occupations 2008. Available at http://www.ilo.org/public/english/bureau/stat/isco/isco08/index.htm [accessed on 28 December 2012].
19. Statistics Korea. 6th Korean Standard Statistical Classification of Occupations. Available at http://kostat.go.kr/kssc/main/MainAction.do?met hod=sub&catgrp=ekssc&catid1=ekssc02&catid2=ekssc02a [accessed on 28 September 2012].
20. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34: S62-9.
21. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998; 21: 2191-2.
22. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-95.
23. Bland JM, Altman DG. Transformations, means, and confidence intervals. BMJ 1996; 312: 1079.
24. Yan LL, Liu K, Matthews KA, Daviglus ML, Ferguson TF, Kiefe CI. Psychosocial factors and risk of hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. JAMA 2003; 290: 2138-48.
25. Aposhian HV, Aposhian MM. Arsenic toxicology: five questions. Chem Res Toxicol 2006; 19: 1-15.
26. Sabbioni E, Fischbach M, Pozzi G, Pietra R, Gallorini M, Piette JL. Cellular retention, toxicity and carcinogenic potential of seafood arsenic: I. lack of cytotoxicity and transforming activity of arsenobetaine in the BALB/3T3 cell line. Carcinogenesis 1991; 12: 1287-91.
27. Cleland B, Tsuchiya A, Kalman DA, Dills R, Burbacher TM, White JW, Faustman EM, Mariën K. Arsenic exposure within the Korean community (United States) based on dietary behavior and arsenic levels in hair, urine, air, and water. Environ Health Perspect 2009; 117: 632-8.
28. Cascio C, Raab A, Jenkins RO, Feldmann J, Meharg AA, Haris PI. The impact of a rice based diet on urinary arsenic. J Environ Monit 2011; 13: 257-65.
29. Mandal BK, Suzuki KT. Arsenic round the world: a review. Talanta 2002; 58: 201-35.
30. Nisianakis P, Giannenas I, Gavriil A, Kontopidis G, Kyriazakis I. Variation in trace element contents among chicken, turkey, duck, goose, and pigeon eggs analyzed by inductively coupled plasma mass spectrometry (ICP-MS). Biol Trace Elem Res 2009; 128: 62-71.
31. Walton FS, Harmon AW, Paul DS, Drobná Z, Patel YM, Styblo M. Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes. Toxicol Appl Pharmacol 2004; 198: 424-33.
32. Díaz-Villaseñor A, Sánchez-Soto MC, Cebrián ME, Ostrosky-Wegman P, Hiriart M. Sodium arsenite impairs insulin secretion and transcription in pancreatic beta-cells. Toxicol Appl Pharmacol 2006; 214: 30-4.